Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
STX6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC101929657 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
FAM13B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP6R3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RTN4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
RALGPS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCAR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZFAND1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMED7-TICAM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUMO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCBP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STRBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POMP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FYTTD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PEX13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XPOT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
METTL10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AIG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on